Editorial: Prognostic factors in hepatocellular carcinoma

Liliana Chemello; Pradeep Kumar Shukla; Marcello Dallio

doi:10.3389/fmed.2023.1331207

Editorial: Prognostic factors in hepatocellular carcinoma

Front Med (Lausanne). 2023 Nov 28:10:1331207. doi: 10.3389/fmed.2023.1331207. eCollection 2023.

Authors

Liliana Chemello¹, Pradeep Kumar Shukla², Marcello Dallio³

Affiliations

¹ Department of Medicine-DIMED, University of Padova, Padua, Italy.
² Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States.
³ Department of Gastroenterology, Hepatology and Digestive Endoscopy, University of Campania Luigi Vanvitelli, Naples, Italy.

No abstract available

Keywords: HCC; biomarkers; hepatocellular carcinoma; immunotherapy; tumor prognosis.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The University of Padova, Department of Medicine-DIMED has provided funds for scientific research on HCC studies with the DOR project number 2023-2327032 to the P.I. LC.